osteoarthritis
Conditions
Interventions
Triamcinolone acetonide, levobupivacaine
Betamethasone, levobupivacaine
saline solution
Sponsors
Kyushu Universit
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: primary total hip arthroplasty
Exclusion criteria
Exclusion criteria: 1) Patients who are difficult to administer lumbar anesthesia 2) Patients requiring total resection of the articular capsule (cases of high dislocation and cases with femoral osteotomy) 3) Patients with poorly controlled diabetic comorbidities and susceptible conditions. 4) Patients with neurological and muscular diseases of the affected limb (e.g., Charcot's joints) 5) Patients with comorbid conditions that may affect consent or assessment, such as dementia, schizophrenia, depression, panic disorder, and generalized anxiety disorder. 6) Patients with a history of allergy to the drugs used in this study. 7) Patients deemed to require lower extremity surgery, including total hip or total knee replacement, within 6 months of participation in this study. 8) Patients who had lower extremity surgery, such as total hip, knee, or osteotomy, in less than 6 months prior to participation in this study. Translated with www.DeepL.com/Translator (free version)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain on a VAS at the end of lumbar spine anesthesia (when lower extremity auto-movement and sensation returned), 6 hours, 12 hours, 24 hours, 3 days, 7 days, at discharge, 4 weeks and 12 weeks post-op. | — |
Countries
Japan
Contacts
Public ContactSatoshi Ikemura
Kyushu University Hospital Orthopedic Surgery
Outcome results
None listed